Skip to main content

LMR Partners LLP

Position in ALNY — Alnylam Pharmaceuticals, Inc.

CIK 1578621 LONDON, X0

Position in ALNY

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$40,402,439
+$15,699,355 QoQ
Shares Held
134,214
+79.8% QoQ
Ownership
0.100%
of shares outstanding
% of Portfolio
0.47%
of 13F equity value
Holder Rank
#95
of 784 holders
Holding Since
Dec 2021
16 quarters on record
Voting authority Sole 89% Shared 11% None 0%

Common Shares in ALNY Over Time

Shares Held

Position Value (USD)

Derivatives in ALNY

reported options exposure · as of Jun 30, 2026
CallValue
$2,197,519
CallShares
7,300
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

LMR Partners LLP holds $188,560,243 across 75 Biotechnology names. ALNY ranks #1 (21.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ALNY
Alnylam Pharmaceuticals, Inc.
This page
134,214 $40,402,439

All Filings in ALNY

Export CSV
28 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $40,402,439 134,214
2026-06-30 $2,197,519 7,300
2026-03-31 $24,703,084 74,661
2025-12-31 $23,470,098 59,022
2025-03-31 $2,430,180 9,000
2025-03-31 $1,566,116 5,800
2024-12-31 $2,800,424 11,901
2024-09-30 $18,561,499 67,489
2024-06-30 $2,179,953 8,971
2024-06-30 $26,705,700 109,900
2024-06-30 $51,491,700 211,900
2024-03-31 $14,825,440 99,200
2024-03-31 $10,666,395 71,371
2024-03-31 $7,562,170 50,600
2023-12-31 $57,423 300
2023-12-31 $10,852,947 56,700
2023-12-31 $5,397,762 28,200
2023-09-30 $10,041,570 56,700
2023-09-30 $53,130 300
2023-09-30 $11,993,920 67,724
2023-06-30 $56,982 300
2023-06-30 $6,589,968 34,695
2023-06-30 $17,455,486 91,900
2023-03-31 $4,235,566 21,144
2022-09-30 $822,057 4,107
2022-06-30 $20,181,702 138,373
2022-03-31 $15,041,295 92,114
2021-12-31 $3,769,424 22,228